<DOC>
	<DOCNO>NCT01447498</DOCNO>
	<brief_summary>In prospective randomise study design investigate , systematic risk factor screen bleed ulcer patient , follow percutaneous coronary intervention ( PCI ) commence one year combination treatment low dose aspirin clopidogrel , follow prophylactic treatment proton pump inhibitor ( PPI ) case increase risk , reduce risk bleed ulcer . Based recently raise suspicion PPI 's , possibly except pantoprazole , reduce effect ADP-receptor inhibitor , pantoprazole chosen prophylaxis screen group , analyse do ascertain whether PPI treatment increase risk coronary event . Further analysis make see whether PPI prophylaxis high risk patient increase compliance antithrombotic treatment reduction side effect , thereby reduce risk myocardial infarction particular stent thrombosis . The study population analyze identify patient , benefit PPI prophylaxis Hypothesis : screening heart patient risk factor bleed ulcer subsequently treat high risk patient PPI reduce incidence bleed ulcer increase compliance antithrombotic treatment ; thereby possibly reduce risk coronary event improve survival . Initial description prevalence risk factor do .</brief_summary>
	<brief_title>Systematic Screening Risk-factors Ulcer Bleeding Before Anti-thrombotic Treatment</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Peptic Ulcer</mesh_term>
	<mesh_term>Coronary Occlusion</mesh_term>
	<mesh_term>Peptic Ulcer Hemorrhage</mesh_term>
	<criteria>Patients PCI stenting balloon dilatation cardiology department Odense University Hospital , Århus University Hospital Ålborg Sygehus , subsequent treatment lowdose aspire clopidogrel another thienopyridine plan one year . previous PCI stenting balloon dilatation treatment clopidogrel prior PCI lack inform consent</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>